COLOGNE, GERMANY – Singleron Biotechnologies announced today the upcoming launch of its GEXSCOPE® FFPE Single Nucleus Transcriptome Sequencing Kit. This solution helps researchers recover comprehensive single nucleus transcriptomic data from formalin-fixed paraffin-embedded (FFPE) tissues and paraformaldehyde-fixed samples. This approach facilitates unbiased discovery by capturing both coding and non-coding RNAs, avoiding the inherent limitations of pre-defined […]
A new in-plate, zero-disruption design enables reproducible organoid culture, downstream processing, and high-resolution imaging in a single 3D cell culture plate MONMOUTH JUNCTION, N.J. — TheWell Bioscience today announced the launch of the VitroPrime™ 3D Culture and Imaging Plate, a next-generation 3D cell culture plate engineered to support organoid and advanced 3D cell culture workflows with minimal […]
Powered by AFA‑enabled workflows that deliver confident RNA‑sequencing data with greater efficiency and helping researchers accelerate discoveries and advance new treatment options. Woburn, MA – Covaris, a PerkinElmer company and a leader in sample preparation workflows in the Life Science industry, today announced the launch of its new truCOVER® Total RNA Library Prep Kit that can deliver […]
New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at the conference in Boston, February 7-11, […]
Patient catchment now includes 187 million+ patient lives, enables advanced analytics and AI modeling for diverse, under-represented patient populations Zurich – BC Platforms, a global leader in healthcare data, technology, and analytics today announced a strategic partnership with OmicsBank, a healthcare AI-ready data infrastructure company specializing in enabling access to large-scale, research-ready longitudinal and multi-modal real-world […]
New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100% transfection efficiency and exogenous gene expression in dynamic suspension (3D) cultures. SEATTLE, WA & TELFORD, PA – Pluristyx, Inc., a leading provider of induced pluripotent stem cell (iPSC)-based technologies, and Solesis, a leader in biomaterials and […]
New ready-to-use kit combines Pluristyx’s high-quality pluripotent cells and mRNA technology with Solesis’ proprietary transfection technology to achieve nearly 100% transfection efficiency and exogenous gene expression in dynamic suspension (3D) cultures. SEATTLE, WA & TELFORD, PA – Pluristyx, Inc., a leading provider of induced pluripotent stem cell (iPSC)-based technologies, and Solesis, a leader in biomaterials and […]
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
QIAsprint Connect marks entry into high-throughput sample processing, enabling labs to scale workflows with flexible protocols, compact design and sustainability-focused features QIAGEN also to showcase new automation systems: QIAsymphony Connect for clinical applications and QIAmini for accessible low-throughput sample processing GERMANTOWN, Md. & VENLO, Netherlands — $QGEN #QIAGEN–QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today […]
SUNNYVALE, Calif. — Integrated DNA Technologies (IDT), a global leader in genomics, today issued the following statement about the recent landmark federal legislation that marks a significant step towards Medicare coverage for FDA-approved multi-early cancer detection (MCED) tests. IDT President Ajay Gannerkote says, “IDT has been a driving force in supporting the development of multi‑cancer […]
Initiative will create one of the world’s largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicine PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research consortium uniting four leading UK institutions, will use the 10x Genomics Xenium […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
